Sector: MedicalMBRK (NASDAQ: MBRK)
Headlines
- MiddleBrook Pharmaceuticals Reports Third Quarter 2009 Results
Nov 05, 2009 07:08 AM | MBRK
- MiddleBrook Pharmaceuticals Schedules Third Quarter 2009 Results Conference Call and Webcast
Oct 15, 2009 08:07 AM | MBRK
- MOXATAG(R) Supports Health Education on FamilyDoctor.org
Oct 12, 2009 04:00 PM | MBRK
- MiddleBrook Pharmaceuticals Announces Sales Force Realignment, Cost-Saving Measures
Sep 01, 2009 09:05 AM | MBRK
- MiddleBrook Fall Could Mean Opportunity
Aug 01, 2008 04:48 PM | MBRK, OSCI
- Twelve Stocks That Aren’t Corrupt Or Manipulated
Jul 07, 2008 12:03 PM | CHDX, ISRG, MBRK, MHGC
- MiddleBrook Pharmaceuticals Reduces Field Sales Force and Corporate Staff, Receives Notice from Nasdaq Regarding Minimum Bid Price Requirement
Dec 03, 2009 05:16 PM | MBRK
- MiddleBrook Pharmaceuticals Reports Second Quarter 2009 Results
Aug 06, 2009 06:19 AM | MBRK
- MiddleBrook Pharmaceuticals Announces $20 Maximum Copay Program for MOXATAG®
Jul 15, 2009 07:14 AM | MBRK
- MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Second Quarter 2009 Financial and Operational Results
Jul 14, 2009 08:35 AM | MBRK
- MiddleBrook Pharmaceuticals Secures $10 Million Revolving Line of Credit
Jul 01, 2009 07:38 AM | MBRK
- MiddleBrook Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 4350
Jun 03, 2009 04:45 PM | MBRK
- MiddleBrook Pharmaceuticals Reports First Quarter 2009 Results
May 07, 2009 07:59 AM | MBRK
- MiddleBrook Pharmaceuticals Launches MOXATAG™ Website, Announces Early Prescription Data for MOXATAG
May 01, 2009 08:07 AM | MBRK
- MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for First Quarter 2009 Financial and Operational Results
Apr 06, 2009 08:43 AM | MBRK
- MiddleBrook Pharmaceuticals Launches MOXATAG™, the First and Only FDA-Approved Once-Daily Amoxicillin
Mar 16, 2009 04:16 PM | MBRK
- Form 4 MiddleBrook Pharmaceutic For: Nov 24 Filed by: BLYTH LORD JAMES (10K)
Nov 25, 2009 06:17 PM
- Form 4 VOGELBAUM MARTIN For: Jun 23 (10K)
Jun 24, 2009 06:59 PM
- Form 4 Sotir Mark R For: Jun 23 (10K)
Jun 24, 2009 06:57 PM
- Form 4 PATE WILLIAM For: Jun 23 (10K)
Jun 24, 2009 06:56 PM
- Form 4 DUGAN RICHARD W For: Jun 23 (10K)
Jun 24, 2009 06:55 PM
- Form 4 DOUGLAS R GORDON For: Jun 23 (10K)
Jun 24, 2009 06:55 PM
- Form 4 WERNER HAROLD R For: Jun 23 (10K)
Jun 24, 2009 05:08 PM
- Form 4 CAVANAUGH JAMES H For: Jun 23 (10K)
Jun 24, 2009 05:02 PM
- Form 4 Miller Timothy L For: Mar 12 (10K)
Mar 12, 2009 06:21 PM
- Form 4 Koos Frank For: Nov 28 (10K)
Dec 02, 2008 06:05 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MBRK
|
Compare to S&P
|
| YTD |
-56.00 %
|
-63.59 %
|
| 4 Weeks |
-32.65 %
|
-36.06 %
|
| 12 Weeks |
-38.32 %
|
-42.56 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 13.04 %
|
|
EPS Growth in Last Year: -5.26 %
|
|
Sales Growth in Last Quarter: -48.09 %
|
|
Sales Growth in Last Quarter: -50.82 %
|
|
